期刊文献+

万古霉素血药浓度监测对临床用药指导意义的分析 被引量:5

Analysis of the guiding significance of detection of vancomycin plasma concentration in clinical medication
下载PDF
导出
摘要 目的探讨万古霉素血药浓度监测对临床使用万古霉素的指导意义。方法采用回顾性分析法,选取宣城市人民医院住院患者27例,采用高效液相色谱法检测万古霉素血药浓度。分析万古霉素血药浓度检测结果及医师对万古霉素剂量调整的反馈情况。结果约有48.15%患者经验使用万古霉素谷浓度不能达到治疗浓度;当谷浓度处于10~20μg/mL、峰浓度>20μg/mL时大部分患者疗效较好。结论肾功能正常的高龄患者仍需谨慎使用大剂量万古霉素,万古霉素血药浓度监测对其临床应用具有指导意义。 Objective To explore the guiding significance of detection of vancomycin plasma concentration in clinical medication.Methods Using retrospective analysis,27 inpatients from the people's hospital of Xuancheng city were selected and the plasma concentration of vancomycin was detected by HPLC.The test results of vancomycin plasma concentration and the feedback of doctors on vancomycin dose adjustment were analyzed.Results Trough concentration of vancomycin used empirically could not reach the treatment concentration in 48.15%of the patients.When the trough concentration was 10-20μg/mL and the peak concentration was more than 20μg/mL,most of the patients had better efficacy.Conclusion High doses of vancomycin should be used with caution in elderly patients with normal renal function.Monitoring of the plasma concentration of vancomycin has great guiding significance for its clinical application.
作者 王敏 WANG Min(the People's Hospital of Xuancheng City,Xuancheng 242000,China)
出处 《临床医学研究与实践》 2020年第16期108-110,共3页 Clinical Research and Practice
关键词 万古霉素 血药浓度 谷浓度 峰浓度 vancomycin plasma concentration trough concentration peak concentration
  • 相关文献

参考文献4

二级参考文献24

  • 1朱曼,郭代红,石莉,宁静,裴保香.2000-2004年我院4种抗癫痫药物血药浓度监测结果分析[J].药物流行病学杂志,2005,14(4):223-225. 被引量:3
  • 2许建明.急性药物性肝损伤诊治建议(草案)[J].中华消化杂志,2007,27(11):765-767. 被引量:349
  • 3中华人民共和国卫生部药政局.抗菌药物临床应用指导原则[S].1993.
  • 4Karam CM, McKinnon PS, Neuhauser MM, et al. Outcomeassessment of minimizing vancomycin monitoring and dosingadjustments[J]. Pharmacotherapy, 1999, 19(3): 257-266.
  • 5Rybak MJ. The pharmacokinetic and pharmacodynamic propertiesof vancomycin[J]. Clin Infect Dis, 2006, 42(Suppl 1): S35-S39.
  • 6Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeuticmonitoring of vancomycin in adult patients: a consensus reviewof the American Society of Health-System Pharmacists, theInfectious Diseases Society of America, and the Society ofInfectious Diseases Pharmacists[J]. Am J Health Syst Pharm,2009, 66(1): 82-98.
  • 7Lee P, DiPersio D, Jerome RN, et al. Approaching and analyzing a large literature on vancomycin monitoring andpharmacokinetics[J]. J Med Libr Assoc, 2007, 95(4): 374-380.
  • 8Hermsen ED, Hanson M, Sankaranarayanan J, et al. Clinicaloutcomes and nephrotoxicity associated with vancomycin troughconcentrations during treatment of deep-seated infections[J].Expert Opin Drug Saf, 2010, 9(1): 9-14.
  • 9张弨,翟所迪.万古霉素个体化用药的方法学评价[J].药学服务与研究,2008,8(5):381-384. 被引量:1
  • 10张弨,翟所迪,刘芳.万古霉素治疗药物监测必要性的系统评价[J].中国临床药理学杂志,2009,25(4):329-333. 被引量:13

共引文献648

同被引文献49

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部